ABVC BioPharma Investor Relations Material
Latest events
Q4 2024
15 Apr, 2025
Q3 2024
14 Nov, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from ABVC BioPharma Inc
Access all reports
ABVC BioPharma Inc. is a U.S.-based biotechnology company engaged in the research, development, and commercialization of pharmaceutical and medical device products. The company focuses on advancing drug candidates and therapies in areas such as oncology, central nervous system disorders, and ophthalmology. ABVC BioPharma leverages partnerships with research institutions and healthcare organizations to develop innovative treatment solutions. ABVC BioPharma Inc. is headquartered in Fremont, California, and its shares are listed on the Nasdaq Stock Market (NASDAQ).
Key slides for ABVC BioPharma Inc
Corporate Presentation
ABVC BioPharma Inc
Corporate Presentation
ABVC BioPharma Inc
Latest articles
)
Eli Lilly: The Pharma Giant Behind Mounjaro and Zepbound
Eli Lilly's journey from insulin pioneer to global pharma giant, leading innovation in diabetes, obesity, and the future of metabolic health.
30 Jun 2025
)
500 Years of Craft, One Family Legacy: Beretta Holding's Global Expansion
How Beretta Holding managed to transform from a 16th-century gun barrel producer into a global industrial group while preserving 500 years of legacy.
27 Jun 2025
)
Shuntaro Furukawa: The Sixth President of Nintendo
Shuntaro Furukawa, Nintendo's sixth president, went from a childhood fan to leading the company through global expansion and the launch of Switch 2.
23 Jun 2025
Ticker symbol
ABVC
Country
🇺🇸 United States